Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 594,697
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $56,737,885
Total People Sold 5 5 6 7
Total Sell Transactions 11 15 24 53
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 1313
  Page 8 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-05-06 4 AS $81.00 $1,620,000 D/D (20,000) 335,324     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-05-06 4 OE $37.46 $749,200 D/D 20,000 355,324     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-05-05 4 AS $84.14 $841,400 D/D (10,000) 335,324     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-05-05 4 OE $37.46 $374,600 D/D 10,000 345,324     -
   Meier Richard A Director   –       •      –    2022-05-02 4 S $82.09 $318,345 D/D (3,878) 104,014     -
   Meier Richard A Director   –       •      –    2022-05-02 4 OE $37.46 $318,410 D/D 8,500 107,892     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2022-05-02 4 AS $80.38 $1,233,592 D/D (15,347) 66,339     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2022-05-02 4 OE $37.46 $574,899 D/D 15,347 81,686     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2022-04-29 4 A $62.41 $21,218 D/D 340 55,417     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-04-29 4 A $62.41 $21,281 D/D 341 335,324     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2022-04-29 4 A $62.41 $21,281 D/D 341 66,339     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-04-29 4 AS $81.95 $409,750 D/D (5,000) 334,983     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-04-29 4 OE $37.46 $187,300 D/D 5,000 339,983     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-04-28 4 AS $83.79 $1,675,800 D/D (20,000) 334,983     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-04-28 4 OE $37.46 $749,200 D/D 20,000 354,983     -
   Davis George Eric EVP, Chief Legal Officer   •       –      –    2022-04-25 4 OE $37.46 $99,981 D/D 2,669 65,998     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-04-18 4 AS $81.91 $1,638,200 D/D (20,000) 334,983     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-04-18 4 OE $37.46 $749,200 D/D 20,000 354,983     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-04-14 4 AS $83.66 $836,600 D/D (10,000) 334,983     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2022-04-14 4 OE $37.46 $374,600 D/D 10,000 344,983     -
   Lawlis V Bryan Director   –       •      –    2022-04-14 4 AS $83.66 $355,555 D/D (4,250) 23,970     -
   Lawlis V Bryan Director   –       •      –    2022-04-14 4 OE $37.46 $159,205 D/D 4,250 28,220     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2022-04-13 4 AS $82.47 $97,315 D/D (1,180) 55,077     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2022-03-30 4 AS $79.56 $109,872 D/D (1,381) 56,257     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2022-03-29 4 AS $79.43 $128,518 D/D (1,618) 57,638     -
  1313 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us